Trials / Unknown
UnknownNCT03754517
Finding the Latent Treponema Pallidum
Finding the Latent Treponema Pallidum of Syphilis With Serofast Status
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Some syphilitic patients remain in a serologically positive state after the recommended therapy. Whether a serofast state could represent a persistent low-level infection by Treponema pallidum is still unknown. The possibility that persistent nontreponemal antibodies after treatment represent persistence of Treponema pallidum was raised by some investigators. The investigators use the Next-Generation Sequencing to test blood plasma, srum, cerebrospinal fluid, aqueous humor, lymph nodes, skin lesion, saliva, semen,milk of serofast patient and other positive and negative controls.
Detailed description
Some syphilitic patients remain in a serologically positive state after the recommended therapy. Whether a serofast state could represent a persistent low-level infection by Treponema pallidum is still unknown. The possibility that persistent nontreponemal antibodies after treatment represent persistence of Treponema pallidum was raised by some investigators. The investigators use the Next-Generation Sequencing to test blood plasma, serum, cerebrospinal fluid, aqueous humor, lymph nodes, skin lesion, saliva, semen,milk of serofast patient and other positive and negative controls.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | RPR Titer | RPR titer; TPPA/FTA-ABS; Next-Generation Sequencing |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2019-11-01
- Completion
- 2019-12-01
- First posted
- 2018-11-27
- Last updated
- 2019-03-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03754517. Inclusion in this directory is not an endorsement.